BD Diagnostics gets CLIA clearance for superbug assay; Vasomedical notches 48% revenue growth in Q2;

 @FierceMedDev: Venture capital funding for medical device firms declined 17% in Q2, according to PwC. More | Follow @FierceMedDev

 @MarkHFierce: An AdvaMed job placement initiative for military veterans has snagged some funding. Formal launch is at AdvaMed 2012. More | Follow @MarkHFierce

 @DamianFierce: KCI is selling its therapeutic support systems business for $275M. More | Follow @DamianFierce

> BD Diagnostics, a Becton, Dickinson ($BDX) division, got a Moderate Complexity rating under CLIA regulations for its MRSA assay, clearing the superbug test to be performed by qualified lab technicians. More

>  Vasomedical, a maker of diagnostic imaging devices and equipment, says it generated $7.7 million in revenue during its 2012 second quarter, up more than 48% from the same period in 2011. Increased sales in China, and booming sales overall, helped drive the numbers jump. Release

> The boost in the use of electronic health records (EHR) in hospitals is driving an increase in the use of medical device integration software, which helps channel device data to EHR systems, InformationWeek reports. Story

> Cardiac Science, a maker of automatic external defibrillators and diagnostic cardiac monitoring devices, has appointed Doug Pepper as its new CFO. Release

> Myriad Genetics ($MYGN), a molecular diagnostics firm, reported a 12% boost in net income for the fiscal fourth quarter, pulling in $29.1 million. The company's revenue grew 24% year-over-year, swelling to $133 million in Q4. Item

> Molecular breast imaging, or breast-specific gamma imaging, can still detect cancers missed by mammography and ultrasound at lower radiation doses, researchers believe. Release

> Spacelabs Healthcare snagged 510(k) clearance for its Capnography Pod, a sidestream gas analyzer compatible with the company's XPREZZON patient monitor. Release

Biotech News

 @FierceBiotech: When Herceptin gets under the skin--literally. More | Follow @FierceBiotech

 @JohnCFierce: AstraZeneca hands over $28M to team with Regulus on cardio pact. More | Follow @JohnCFierce

 @RyanMFierce: What does translational research mean in practice? Here's a good piece from the front lines in the U.K. More | Follow @RyanMFierce

> Eisai chief outlines Belviq sales effort, deal strategy. Spotlight

> Open-innovation projects turn old R&D wisdom 'on its head'. Story

> R&D experts applaud new initiative to validate biomedical studies. Article

> Struggling Tengion threatens bankruptcy as it scrambles for cash. News

Pharma News

 @FiercePharma: Watson sues FDA for delay of generic Actos launch. More | Follow @FiercePharma

> New pharma trial: Pfizer, GSK, J&J test 1-page drug information sheets. News

> GSK sells off more low-margin brands as it focuses on HGS. Article

> Lawmakers pressure Gilead on Quad price ahead of approval. Story

Biomarkers News

> Drug-biomarker combo pinpoints prostate cancer. Story

> Genes pinpoint kids' bone cancer outcomes. News

> Alzheimer's disease blood test comes ever closer. Article

> Urine proteomics could pinpoint diabetic nephropathy. More

Drug Delivery News

> pSivida--focusing on delivery to the eye. Editor's Corner

> Oral nanoparticle vaccine could protect against HIV. Spotlight

> Hydrogel foams can deliver drugs for 6 months. More

> Nanoplexes deliver personalized medicine in cancer. Story

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.